Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-24-009294
Filing Date
2024-03-07
Accepted
2024-03-07 18:00:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 293835
  Complete submission text file 0001493152-24-009294.txt   295417
Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

EIN.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92222 | Film No.: 24731619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)